SENESTECH INC (SNES)

Company Profile

Senestech Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Phoenix, Arizona and currently employs 25 full-time employees. The company went IPO on 2016-12-08. SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The firm has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The firm's technology can also be applied to other mammalian species.

Company Info

SENESTECH INC

777 W. Pinnacle Peak Road, Suite B104

Phoenix ARIZONA 85027

P: 19287794143

CEO: Kenneth Siegel

Employees: 25

Website: https://senestech.com/